Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 219

1.

APOL1 risk variants, race, and progression of chronic kidney disease.

Parsa A, Kao WH, Xie D, Astor BC, Li M, Hsu CY, Feldman HI, Parekh RS, Kusek JW, Greene TH, Fink JC, Anderson AH, Choi MJ, Wright JT Jr, Lash JP, Freedman BI, Ojo A, Winkler CA, Raj DS, Kopp JB, He J, Jensvold NG, Tao K, Lipkowitz MS, Appel LJ; AASK Study Investigators; CRIC Study Investigators.

N Engl J Med. 2013 Dec 5;369(23):2183-96. doi: 10.1056/NEJMoa1310345. Epub 2013 Nov 9.

2.

Examination of Potential Modifiers of the Association of APOL1 Alleles with CKD Progression.

Chen TK, Choi MJ, Kao WH, Astor BC, Scialla JJ, Appel LJ, Li L, Lipkowitz MS, Wolf M, Parekh RS, Winkler CA, Estrella MM, Crews DC.

Clin J Am Soc Nephrol. 2015 Dec 7;10(12):2128-35. doi: 10.2215/CJN.05220515. Epub 2015 Oct 1.

PMID:
26430087
3.

Effect of Genetic African Ancestry on eGFR and Kidney Disease.

Udler MS, Nadkarni GN, Belbin G, Lotay V, Wyatt C, Gottesman O, Bottinger EP, Kenny EE, Peter I.

J Am Soc Nephrol. 2015 Jul;26(7):1682-92. doi: 10.1681/ASN.2014050474. Epub 2014 Oct 27.

4.

Association of APOL1 variants with mild kidney disease in the first-degree relatives of African American patients with non-diabetic end-stage renal disease.

Freedman BI, Langefeld CD, Turner J, Núñez M, High KP, Spainhour M, Hicks PJ, Bowden DW, Reeves-Daniel AM, Murea M, Rocco MV, Divers J.

Kidney Int. 2012 Oct;82(7):805-11. doi: 10.1038/ki.2012.217. Epub 2012 Jun 13.

5.

APOL1 Genotype and Glomerular and Tubular Kidney Injury in Women With HIV.

Jotwani V, Shlipak MG, Scherzer R, Parekh RS, Kao WH, Bennett M, Cohen MH, Nowicki M, Sharma A, Young M, Tien PC, Parikh CR, Estrella MM.

Am J Kidney Dis. 2015 Jun;65(6):889-98. doi: 10.1053/j.ajkd.2015.02.329. Epub 2015 Apr 24.

6.

Apolipoprotein L1 gene variants associate with hypertension-attributed nephropathy and the rate of kidney function decline in African Americans.

Lipkowitz MS, Freedman BI, Langefeld CD, Comeau ME, Bowden DW, Kao WH, Astor BC, Bottinger EP, Iyengar SK, Klotman PE, Freedman RG, Zhang W, Parekh RS, Choi MJ, Nelson GW, Winkler CA, Kopp JB; SK Investigators.

Kidney Int. 2013 Jan;83(1):114-20. doi: 10.1038/ki.2012.263. Epub 2012 Jul 25.

7.

APOL1 genetic variants, chronic kidney diseases and hypertension in mixed ancestry South Africans.

Matsha TE, Kengne AP, Masconi KL, Yako YY, Erasmus RT.

BMC Genet. 2015 Jun 26;16:69. doi: 10.1186/s12863-015-0228-6.

8.

Target organ damage in African American hypertension: role of APOL1.

Freedman BI, Murea M.

Curr Hypertens Rep. 2012 Feb;14(1):21-8. doi: 10.1007/s11906-011-0237-4. Review.

9.

Population-based risk assessment of APOL1 on renal disease.

Friedman DJ, Kozlitina J, Genovese G, Jog P, Pollak MR.

J Am Soc Nephrol. 2011 Nov;22(11):2098-105. doi: 10.1681/ASN.2011050519. Epub 2011 Oct 13.

10.

Re-Sequencing of the APOL1-APOL4 and MYH9 Gene Regions in African Americans Does Not Identify Additional Risks for CKD Progression.

Hawkins GA, Friedman DJ, Lu L, McWilliams DR, Chou JW, Sajuthi S, Divers J, Parekh RS, Li M, Genovese G, Pollack MR, Hicks PJ, Bowden DW, Ma L, Freedman BI, Langefeld CD.

Am J Nephrol. 2015;42(2):99-106. doi: 10.1159/000439448. Epub 2015 Sep 8.

11.

Increased burden of cardiovascular disease in carriers of APOL1 genetic variants.

Ito K, Bick AG, Flannick J, Friedman DJ, Genovese G, Parfenov MG, Depalma SR, Gupta N, Gabriel SB, Taylor HA Jr, Fox ER, Newton-Cheh C, Kathiresan S, Hirschhorn JN, Altshuler DM, Pollak MR, Wilson JG, Seidman JG, Seidman C.

Circ Res. 2014 Feb 28;114(5):845-50. doi: 10.1161/CIRCRESAHA.114.302347. Epub 2013 Dec 30.

12.

Plasma apolipoprotein L1 levels do not correlate with CKD.

Bruggeman LA, O'Toole JF, Ross MD, Madhavan SM, Smurzynski M, Wu K, Bosch RJ, Gupta S, Pollak MR, Sedor JR, Kalayjian RC.

J Am Soc Nephrol. 2014 Mar;25(3):634-44. doi: 10.1681/ASN.2013070700. Epub 2013 Nov 14.

13.

Clinical phenotype of APOL1 nephropathy in young relatives of patients with end-stage renal disease.

Anyaegbu EI, Shaw AS, Hruska KA, Jain S.

Pediatr Nephrol. 2015 Jun;30(6):983-9. doi: 10.1007/s00467-014-3031-0. Epub 2014 Dec 23.

14.

Testing for High-Risk APOL1 Alleles in Potential Living Kidney Donors.

Riella LV, Sheridan AM.

Am J Kidney Dis. 2015 Sep;66(3):396-401. doi: 10.1053/j.ajkd.2015.04.046. Epub 2015 Jun 3.

PMID:
26049628
15.

High population frequencies of APOL1 risk variants are associated with increased prevalence of non-diabetic chronic kidney disease in the Igbo people from south-eastern Nigeria.

Ulasi II, Tzur S, Wasser WG, Shemer R, Kruzel E, Feigin E, Ijoma CK, Onodugo OD, Okoye JU, Arodiwe EB, Ifebunandu NA, Chukwuka CJ, Onyedum CC, Ijoma UN, Nna E, Onuigbo M, Rosset S, Skorecki K.

Nephron Clin Pract. 2013;123(1-2):123-8. doi: 10.1159/000353223. Epub 2013 Jul 13.

PMID:
23860441
16.

APOL1 Genotype and Race Differences in Incident Albuminuria and Renal Function Decline.

Peralta CA, Bibbins-Domingo K, Vittinghoff E, Lin F, Fornage M, Kopp JB, Winkler CA.

J Am Soc Nephrol. 2016 Mar;27(3):887-93. doi: 10.1681/ASN.2015020124. Epub 2015 Jul 15.

PMID:
26180129
17.

Hemostatic Factors, APOL1 Risk Variants, and the Risk of ESRD in the Atherosclerosis Risk in Communities Study.

Tin A, Grams ME, Maruthur NM, Astor BC, Couper D, Mosley TH, Fornage M, Parekh RS, Coresh J, Kao WH.

Clin J Am Soc Nephrol. 2015 May 7;10(5):784-90. doi: 10.2215/CJN.08340814. Epub 2015 Apr 17.

18.

Histopathologic findings associated with APOL1 risk variants in chronic kidney disease.

Larsen CP, Beggs ML, Saeed M, Ambruzs JM, Cossey LN, Messias NC, Walker PD, Freedman BI.

Mod Pathol. 2015 Jan;28(1):95-102. doi: 10.1038/modpathol.2014.92. Epub 2014 Aug 1.

19.

End-stage renal disease in African Americans with lupus nephritis is associated with APOL1.

Freedman BI, Langefeld CD, Andringa KK, Croker JA, Williams AH, Garner NE, Birmingham DJ, Hebert LA, Hicks PJ, Segal MS, Edberg JC, Brown EE, Alarcón GS, Costenbader KH, Comeau ME, Criswell LA, Harley JB, James JA, Kamen DL, Lim SS, Merrill JT, Sivils KL, Niewold TB, Patel NM, Petri M, Ramsey-Goldman R, Reveille JD, Salmon JE, Tsao BP, Gibson KL, Byers JR, Vinnikova AK, Lea JP, Julian BA, Kimberly RP; Lupus Nephritis–End‐Stage Renal Disease Consortium.

Arthritis Rheumatol. 2014 Feb;66(2):390-6. doi: 10.1002/art.38220.

20.

Apolipoprotein L1 nephropathy risk variants associate with HDL subfraction concentration in African Americans.

Freedman BI, Langefeld CD, Murea M, Ma L, Otvos JD, Turner J, Antinozzi PA, Divers J, Hicks PJ, Bowden DW, Rocco MV, Parks JS.

Nephrol Dial Transplant. 2011 Nov;26(11):3805-10. doi: 10.1093/ndt/gfr542. Epub 2011 Sep 19.

Items per page

Supplemental Content

Write to the Help Desk